PubMed COVID-19 Clinical Care
2971 - 2980 of 7414 results found
COVID-19 in patients with rheumatological diseases in the Eastern Province of Saudi Arabia
Description
The severity of the 2019 coronavirus disease (COVID-19) and its effects remain unpredictable. Certain factors, such as obesity, hypertension, and type 2 diabetes mellitus, may increase the severity of the disease. Rheumatology experts suggest that
Convalescent Adaptive Immunity is Highly Heterogenous after SARS-CoV-2 Infection
Description
Optimal detection strategies for effective convalescent immunity after SARS-CoV-2 infection and vaccination remain unclear. The objective of this study was to characterize convalescent immunity targeting the SARS-CoV-2 spike protein using a
Celiprolol and sympatho-immune interface in COVID-19
Description
No abstract
Cycle Threshold Values as Indication of Increasing SARS-CoV-2 New Variants, England, 2020-2022
Description
Early detection of increased infections or new variants of SARS-CoV-2 is critical for public health response. To determine whether cycle threshold (Ct) data from PCR tests for SARS-CoV-2 could serve as an early indicator of epidemic growth, we
Copenhagen Psychosocial "Work Organization and Job Content" as a Higher-Order Construct in Relation to Workers' Health: The Moderating Role of Leadership Quality
Description
CONCLUSION/IMPLICATIONS: This study has significant implications for researchers, poultry feed mill owners, policymakers, and regulatory bodies. Additionally, the methodological contribution of utilizing WOJC as a higher-order construct provides
Cellular Stress Responses against Coronavirus Infection: A Means of the Innate Antiviral Defense
Description
Cellular stress responses are crucial for maintaining cellular homeostasis. Stress granules (SGs), activated by eIF2α kinases in response to various stimuli, play a pivotal role in dealing with diverse stress conditions. Viral infection, as one kind
Comparative effectiveness and duration of protection of ChAdOx1, CoronaVac, BNT162b2, mRNA-1273, and Ad26.COV2.S COVID-19 vaccines for symptomatic and hospitalized Mu, Delta, and Omicron: A test-negative case-control study
Description
CONCLUSION: Our study provides further evidence on the protective effect of mRNA vaccines for Omicron, and warrant that the duration of protection against symptomatic infection may last for only a few months.
Changes in sleep quality of children with epilepsy and anxiety of their caregivers after COVID-19 infection: a case-series report
Description
CONCLUSIONS: COVID-19 infection did not cause an increase in seizures in CWEs, nor did it worsen their sleep quality of them or aggravate the anxiety of their caregivers.
COVID-19: An Overview of SARS-CoV-2 Variants-The Current Vaccines and Drug Development
Description
The world is presently in crisis facing an outbreak of a health-threatening microorganism known as COVID-19, responsible for causing uncommon viral pneumonia in humans. The virus was first reported in Wuhan, China, in early December 2019, and it
